tiprankstipranks
Insmed (INSM)
NASDAQ:INSM

Compare Insmed (INSM) vs. Competitors

1,082 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Insmed
$160.18
$34.53B
-29.12
146.54%
16 Buy
0 Hold
0 Sell
Strong Buy
BioMarin Pharmaceutical
$57.20
$11.00B
32.67
2.34%
13 Buy
3 Hold
0 Sell
Strong Buy
Incyte
$95.89
$19.08B
14.98
68.32%
8 Buy
8 Hold
1 Sell
Moderate Buy
Genmab
$28.40
$17.20B
19.86
57.95%
8 Buy
2 Hold
0 Sell
Strong Buy
BioNTech SE
$92.08
$23.14B
-17.95
6.27%
14 Buy
2 Hold
0 Sell
Strong Buy
Royalty Pharma
$47.90
$27.63B
21.65
55.27%
7 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INSM
Insmed
160.18
95.37
147.15%
BMRN
BioMarin Pharmaceutical
57.20
0.88
1.56%
INCY
Incyte
95.89
40.72
73.81%
GMAB
Genmab
28.40
10.39
57.69%
BNTX
BioNTech SE
92.08
-1.04
-1.12%
RPRX
Royalty Pharma
47.90
17.42
57.13%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts